Literature DB >> 3073831

A clinical and histopathological review of intermediate uveitis ("pars planitis").

J W Eichenbaum, A H Friedman, A E Mamelok.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3073831      PMCID： PMC1629315     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  14 in total

1.  CHRONIC CYCLITIS.

Authors:  S J KIMURA; M J HOGAN
Journal:  Arch Ophthalmol       Date:  1964-02

2.  Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole.

Authors:  R B WELCH; A E MAUMENEE; H E WAHLEN
Journal:  Arch Ophthalmol       Date:  1960-10

3.  The use of chlorambucil in intractable idiopathic uveitis.

Authors:  W A Godfrey; W V Epstein; G R O'Connor; S J Kimura; M J Hogan; R A Nozik
Journal:  Am J Ophthalmol       Date:  1974-09       Impact factor: 5.258

4.  Fluorescein angiography of peripheral uveitis.

Authors:  R C Pruett; J Brockhurst; N F Letts
Journal:  Am J Ophthalmol       Date:  1974-04       Impact factor: 5.258

5.  Treatment of peripheral uveoretinitis by cryotherapy.

Authors:  T M Aaberg; T J Cesarz; R R Flickinger
Journal:  Am J Ophthalmol       Date:  1973-04       Impact factor: 5.258

6.  The fine structure of the vitreous base of the human eye and pathogenesis of pars planitis.

Authors:  J Gärtner
Journal:  Am J Ophthalmol       Date:  1971-06       Impact factor: 5.258

7.  Peripheral uveitis in the owl monkey. Experimental model.

Authors:  E Hultsch
Journal:  Mod Probl Ophthalmol       Date:  1977

8.  Treatment of intraocular inflammatory disease with cyclosporin A.

Authors:  R B Nussenblatt; A G Palestine; A H Rook; I Scher; W B Wacker; I Gery
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

9.  Uveitis. II. Peripheral uveitis: clinical description, complications and differential diagnosis.

Authors:  R J BROCKHURST; C L SCHEPENS; I D OKAMURA
Journal:  Am J Ophthalmol       Date:  1960-06       Impact factor: 5.258

10.  Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis.

Authors:  M M Yokoyama; Y Matsui; H M Yamashiroya; M J O'Donnell; C H Tseng; D A Snyder; H H Tessler; R G Crispen; C M Zimjewski
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-03       Impact factor: 4.799
View more
  5 in total

1.  Pars planitis: epidemiology and clinical outcome in a large community hospital in Mexico City.

Authors:  G Ortega-Larrocea; L Arellanes-Garcia
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

2.  Classification Criteria For Pars Planitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

Review 3.  Immunopathogenic Background of Pars Planitis.

Authors:  Joanna Przeździecka-Dołyk; Agnieszka Węgrzyn; Anna Turno-Kręcicka; Marta Misiuk-Hojło
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-10-05       Impact factor: 4.291

Review 4.  Ischemic retinal vasculitis and its management.

Authors:  Lazha Talat; Sue Lightman; Oren Tomkins-Netzer
Journal:  J Ophthalmol       Date:  2014-04-15       Impact factor: 1.909

5.  Imbalance in PB IL-17-Secreting and Regulatory Cells in Pars Planitis Is Associated with Dysregulation of IFN-γ-Secreting Cells, Especially in Patients with Clinical Complications.

Authors:  Agata Kosmaczewska; Joanna Przeździecka-Dołyk; Anna Turno-Kręcicka; Lidia Ciszak; Aleksandra Szteblich; Agnieszka Węgrzyn; Irena Frydecka; Marta Misiuk-Hojło
Journal:  Mediators Inflamm       Date:  2020-07-31       Impact factor: 4.711
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.